Exploratory study on glycemic control improvement for patients with diabetes mellitus by appropriate re-education on insulin self-injection technique during COVID-19 pandemic

Diabetes Res Clin Pract. 2023 Jan:195:110192. doi: 10.1016/j.diabres.2022.110192. Epub 2022 Nov 28.

Abstract

Aims: To conduct a study on glycemic control improvement by appropriate re-education on the self-injection technique (SIT) in patients with diabetes mellitus undergoing insulin therapy.

Methods: Patients who received appropriate SIT and were treated with insulin for more than a year were re-educated. For the observation period of six months, the subjects' SIT was checked, and hemoglobin A1c (HbA1c) levels were measured at each visit. HbA1c levels, insulin doses, and behavioral changes in SIT were investigated at baseline and at the end of the observation period.

Results: In the per-protocol set population, the HbA1c level decreased by 0.2 % (2.0 mmol/mol) on average, showing a significant difference (p = 0.009). No significant difference was observed in the proportion of subjects with decreased HbA1c levels, changes in total daily insulin doses, or blood glucose levels. Four of the six SIT items covered by re-education were improved.

Conclusions: Providing re-education on insulin SIT was considered effective in reducing HbA1c levels and improving adherence to proper SIT.

Keywords: COVID-19 pandemic; Diabetes mellitus; Insulin treatment; Re-education; Self-injection technique.

MeSH terms

  • Blood Glucose
  • COVID-19*
  • Diabetes Mellitus* / chemically induced
  • Diabetes Mellitus* / drug therapy
  • Diabetes Mellitus, Type 2* / drug therapy
  • Glycated Hemoglobin
  • Glycemic Control
  • Humans
  • Hypoglycemic Agents
  • Insulin
  • Insulin, Regular, Human / therapeutic use
  • Pandemics
  • Self Administration*

Substances

  • Blood Glucose
  • Glycated Hemoglobin
  • Hypoglycemic Agents
  • Insulin
  • Insulin, Regular, Human